Aging Populations And Precision Medicine Will Expand Biologics Access
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
01 Jun 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
JP¥10,761.16
42.3% undervalued intrinsic discount20 Aug
JP¥6,206.00
1Y
-12.6%7D
-0.9%